# Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)

> **NCT03216200** · NA · COMPLETED · sponsor: **DeviceFarm, Inc.** · enrollment: 5 (actual)

## Conditions studied

- Onychomycosis of Toenail
- Onychomycosis

## Interventions

- **DEVICE:** plasma treatment

## Key facts

- **NCT ID:** NCT03216200
- **Lead sponsor:** DeviceFarm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-07
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-07-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216200, "Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03216200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*